Semaglutide in Fairfield County

Semaglutide medications are a solution for weight management that improves your overall health and well-being. They provide a way to reduce body weight, decrease hunger and cravings, and increase fat burn. Simple, weekly subcutaneous fat injections are perfect for those struggling with their weight and at least one weight-related condition, i.e., high blood pressure, type-2 diabetes, or high cholesterol.

If you are struggling with being overweight and nothing seems to be helping, Semaglutide may be the answer. New Beauty & Wellness is proud to be the primary provider of Semaglutide in Connecticut. Our experienced professionals are here to create a custom treatment plan that helps you reach your goals.

Call 203-720-6673 (Westport) or 203-286-5909 (New Canaan) for Semaglutide in Fairfield County.

With a staggering 70% of American adults obese or overweight, it is no surprise that the new Semaglutide weight loss treatment is becoming increasingly popular. Non-mood-altering weight loss injections are:

Many people face challenges with their weight and related health issues, such as heart disease and type 2 diabetes. Fortunately, Semaglutide treatments offer renewed hope for effective weight loss and improved health. Most people see a decline in blood sugar levels within the first week of treatment. Full effects take eight weeks or longer.

Semaglutide mimics the effects of a natural hormone called glucagon-like peptide-1 (GLP-1). This hormone targets the area of the brain that regulates appetite and food intake. The medication’s dose gradually increases, depending on your body’s response to treatment.

Semaglutide influences the brain’s reward pathways, altering how you perceive food and decreasing cravings for high-calorie foods. It also slows gastric emptying and prolongs digestion, which helps control food intake. Together, these mechanisms in the brain and body help facilitate weight loss and improve metabolic health. Several clinical studies and trials show that Semaglutide is effective for weight loss. Semaglutide patients receiving 2.4 mg lost a mean of 6% of their body weight by the 12th week and 12% of their body weight by the 28th week. As always, results will be different for each person.*

Semaglutide before and after images show the type of weight loss possible with this new treatment.*

*As with any weight program or treatment, results and the amount of body weight lost will vary from person to person. However, this weight loss treatment changes how your body metabolizes food. This means you can burn fat more efficiently. When paired with a healthy diet and exercise, Semaglutide treatments provide exceptional weight loss results. In addition, this medication also improves your overall health and well-being.

As incredible as it is, Semaglutide isn’t a suitable treatment for everyone. It is not a medication for anyone with a personal or family history of Pancreatitis, Medullary Thyroid Cancer (MTC), or Multiple Endocrine Neoplasia Syndrome (MEN). Semaglutide treatment is not suitable for you if you are at risk of developing a thyroid C-cell tumor. Others who are not candidates include those with a history of allergic reactions to medication or any inert solution ingredients.

Adult candidates should have a BMI greater than 30 or a BMI of 27 or higher with one or more weight-related medical problems. If you are committed to lifestyle changes and have not achieved success with other weight loss strategies, our medical supervision may be the solution.

Another name you may hear in the weight loss industry is Mounjaro. We want to provide accurate information to everyone searching online to find the differences between Mounjaro and Semaglutide. Semaglutide acts as a GLP-1 receptor agonist that binds to and activates the GLP-1 receptor. This stimulates insulin release from the pancreas in a glucose-dependent manner. Semaglutide slows digestion so you can feel full for extended periods, and your appetite is decreased, leading to weight loss.

Mounjaro (Tirzepatide) is in the same class as Semaglutide and has been a successful diabetes medication. Mounjaro is an incretin mimetic medication but differs by acting on both GIP and GLP-1 receptors. As a dual-acting GIP and GLP-1, Mounjaro lowers fasting and postprandial glucose concentrations. After going through many clinical studies and trials, Mounjaro can decrease food intake, reduce body weight, and improve health in patients struggling with weight-related issues, including type-1 diabetes mellitus. While it has successfully reduced body mass index, Mounjaro is not yet FDA-approved for weight loss.

Take control of your health and finally shed the weight hindering your well-being. New Beauty & Wellness offers Semaglutide treatments to our Westport and New Canaan clients. This medication can help turn your body into a fat-burning machine, control your hunger, and finally lose those pounds.

Call 203-720-6673 (Westport) or 203-286-5909 (New Canaan) to get weight loss injections in Fairfield County.

SOURCES

¹ Once-Weekly Semaglutide in Adults with Overweight or Obesity, The New England Journal of Medicine

² New Drug Treatment for Chronic Weight Management, First Since 2014, The U.S. Food and Drug Administration

DISCLAIMER

You agree to be contacted by New Beauty & Wellness by submitting this form; regarding marketing messages by text, phone, or email. We commit to respecting and protecting your private information. At any time you are able to unsubscribe from these messages. For more information regarding our Privacy Policy, please review here.

* Before and after images reflect real results from real patients, although individual results may vary. No treatment is promised to provide permanent results. A guarantee is neither provided nor implied. Statements estimating treatment duration and the number of treatments required are based on the typical experience of our patients, however, individual experiences may vary.

* Contraindications to Semaglutide include a personal or family history of medullary thyroid cancer, allergy to Semaglutide, Type 1 Diabetes or history of Diabetic Ketoacidosis, personal or family history of Multiple Endocrine Neoplasia, personal history of Pancreatitis, renal impairment or kidney disease, gallbladder disease, or concurrent use of anti-diabetic medications or insulin.